Table 1.
Enrolled Participant Characteristics by HIV Infection Status
| HIV Negative (N = 176) |
HIV Positive (N = 63) |
Total (N = 239) |
p-value | |
|---|---|---|---|---|
| Age of Enrollment (median, IQR) | 57.7 (47.2–67.0) | 47.4 (44.1–54.1) | 53.7 (45.8–63.5) | <0.0001 |
| Anatomic Breast Cancer Stage (n, %) | 0.75 | |||
| I | 16 (9.1) | 7 (11.1) | 23 (9.6) | |
| II | 84 (47.7) | 32 (50.8) | 116 (48.5) | |
| III | 76 (43.2) | 24 (38.1) | 100 (41.8) | |
| HER2 Status (n, %) | 0.77 | |||
| Negative | 120 (68.2) | 43 (68.3) | 163 (68.2) | |
| Positive | 42 (23.9) | 16 (25.4) | 58 (24.3) | |
| Equivocal | 11 (6.3) | 4 (6.4) | 15 (6.3) | |
| Missing | 3 (1.7) | 0 (0.0) | 3 (1.3) | |
| Adjuvant Endocrine Therapy (n,%) | 0.09 | |||
| Tamoxifen | 136 (77.3) | 55 (87.3) | 191 (79.9) | |
| Aromatase Inhibitor | 40 (22.7) | 8 (12.7) | 48 (20.1) | |
| Years since Breast Cancer Diagnosis (median, IQR) | 3.4 (2.0–4.2) | 2.9 (1.2–3.9) | 3.3 (1.8–4.1) | 0.08 |
| Number of Other Medications Used (Non-ART) (median, IQR) | 1 (0–3) | 0 (0–2) | 1 (0–2) | 0.04 |
| Married/Domestic Partner (n, %) | 88 (50.0) | 28 (44.4) | 116 (48.5) | 0.49 |
| Tobacco Smoking (n, %) | 17 (9.7) | 6 (9.5) | 23 (9.7) | 0.97 |
| Alcohol Use (n, %) | 36 (20.5) | 20 (31.8) | 56 (23.4) | 0.07 |
| Wealth Percentile (n, %) | 0.0003 | |||
| < 20th (Lowest) | 12 (6.9) | 6 (9.5) | 18 (7.6) | |
| 20th to < 40th | 30 (17.2) | 28 (44.4) | 58 (24.5) | |
| 40th to < 60th | 46 (26.4) | 8 (12.7) | 54 (22.8) | |
| 60th to < 80th | 46 (26.4) | 11 (17.5) | 57 (24.1) | |
| ≥ 80th | 40 (23.0) | 10 (15.9) | 50 (21.1) |
Abbreviations: ART – antiretroviral therapy; HER2 - human epidermal growth factor receptor 2